2.Predictive value of corrected QT interval, corrected Tp-e interval and Tp-e/QT ratio on malignant arrhythmia events in acute ST-segment elevation myocardial infarction patients undergoing thrombolysis
Wen-Tao XIAO ; Xian-Pei WANG ; Chuan-Yu GAO ; Juan-Juan YAN ; Mu-Wei LI ; You ZHANG ; Jing-Jing LIU
Chinese Journal of Cardiology 2012;40(6):473-476
Objective The prognostic value of corrected QT interval(QTc),corrected Tp-e interval (Tp-ec) and Tp-e/QT ratio on occurrence of malignant arrhythmia events (MAE) in acute ST-segment elevation myocardial infarction (STEMI) patients underwent successful thrombolysis was explored and the potential association of these indices with MAE was analyzed.Methods Fifty-seven STEMI patients underwent successful thrombolytic therapy within 6 hours after admission and conservative medical treatment were included.QTc,Tp-ec,Tp-e/QT ratio were obtained and calculated in infarct-related electrocardiograph leads and non-infarct-related leads before thrombolysis,(7 ± 1 ) days and (30 ±3 ) days after thrombolysis respectively,and incidence of MAE up to 30 days after thrombolysis was analyzed.Sixty age and gender matched normal subjects served as control group.Results ( 1 ) QTc,Tp-ec,Tp-e/QT in infarct-related and non-infarct-related leads in STEMI group before thrombolysis were significantly higher than those in control group( all P <0.05 ),and values from the infarct-related leads were significantly higher than those from non-infarct-related leads in STEMI group ( all P < 0.05 ).QTc,Tp-ec and Tp-e/QT all significantly and continuously reduced from 7 days and at 30 days post thrombolysis compared the before thrombolysis( P <0.05 vs.before thrombolysis).( 2 ) Tp-ec ≥ 100 ms and Tp-e/QT ratio ≥0.25 before thrombolysis in infarct-related leads were linked with higher incidence of MAE within 30 days post thrombolysis in this patient cohort [28.1% (9/32) vs.40% ( 1/25),27.8% (10/36) vs.0,respectively,all P < 0.05 ].Conclusion QTc,Tp-ec and Tp-e/QT values decreased post successful thrombolysis in STEMI patients and higher Tp-ec and Tp-e/QT values before thrombolysis in STEMI patients were related with higher MAE incidence up to 30 days post successful thrombolysis in this patient cohort.
3.Epidemiological study and clinical analysis of 931 children with hand foot and mouth disease in Yantai.
Ji-Guan YU ; You-De LIU ; Ling-Yan QIAO ; Chun-Juan WANG
Chinese Journal of Experimental and Clinical Virology 2011;25(5):374-376
OBJECTIVETo discuss the epidemiological and clinical characteristics of the hospitalized children with hand foot and mouth disease (HFMD) in Yantai area.
METHODSEpidemiological and clinical data of HFMD children from 2009 to 2010 were summarized and analyzed retrospectively.
RESULTSMost of the infected (94.6%) were under 5 years old and the ratio between male and female was 1.5: 1. Oral mucosal pox or ulcer as well as hand and foot rashes were observed in all 931 patients. Fever and neurological disorders occurred in 840 (90.2%) and 121 (13.0%) patients respectively. The incidence was positively correlated with air temperature (r = 0.887, P < 0.001), with a peak in April to September (88.9%). The ratio of children from countryside, total duration of fever, serum concentration of c-reacting protein (CRP) and fasting blood glucose (FBG) were significantly higher in severe cases than in those mild ones. Multivariate analysis showed longer mean duration of fever( Odds ratio [OR], 1.491; 95% confidence interval [ CI] 1.170-1.901; P = 0.001) and hyperglycemia (OR, 1.124; 95% CI 1.016-1.245; P = 0.024) were independent risk factors of severity.
CONCLUSIONChildren younger than 5 years old are susceptible to HFMD and most cases occur in April to September. The monthly incidence is positively correlated with temperature of that month. Longer duration of fever and hyperglycemia are independent risk factors for severity. Most cases could have a favorable prognosis after timely diagnosis and proper intervention.
Adolescent ; Child ; Child, Preschool ; China ; epidemiology ; Epidemiologic Studies ; Female ; Hand, Foot and Mouth Disease ; epidemiology ; Humans ; Incidence ; Infant ; Male ; Retrospective Studies ; Seasons ; Temperature
4.Prognostic significance of preoperative serum gamma glutamyl transpeptidase level in patients with hepatocellular carcinoma after liver resection
Yu ZHANG ; Lijun WU ; Liang MA ; Bangde XIANG ; Tao BAI ; Jie CHEN ; Xuemei YOU ; Xinhua ZHAO ; Juan TANG ; Lequn LI
Chinese Journal of General Surgery 2017;32(4):310-313
Objective To evaluate the prognostic significance of preoperative serum gamma glutamyl transpeptidase (GGT) level in patients with hepatocellular carcinoma (HCC) after liver resection.Methods A total of 432 patients undergoing hepatectomy for HCC were divided into normal GGT group (175 patients with GGT ≤ 50 U/L) and high GGT group (257 patients with GGT > 50 U/L).After balancing baseline characteristics by propensity score analysis,disease-free survival (DFS) and overall survival (OS) were compared between the two groups.Independent risk factors influencing DFS and OS were identified by Cox multivariate analyses.Results Propensity score analysis identified 124 matched pairs of patients from each group.In the propensity-matched cohort,DFS at 1,3,and 5 years in normal GGT group (69.3%,36.1%,12.8%) was significantly higher than that in high GGT group (60.6%,18.7%,7.5%;P=0.039).OSat1,3,and5 years innommlGGTgroup (90.7%,73.7%,66.1%) was also significantly higher than that in high GGT group (89.2%,63.6%,43.3%;P =0.024).COX multivariate analyses revealed that alpha-fetoprotein ≥400 ng/ml,GGT > 50 U/L,macrovascular invasion,tumor size ≥ 10 cm,and tumor number ≥3 were independent risk factors for DFS in patients with HCC after liver resection.Albumin < 35 g/L,GGT > 50 U/L,macrovascular invasion,tumor size ≥ 10 cm,and tumor number ≥ 3 were identified as independent risk factors for OS.Conclusions Preoperative serum GGT level is an independent factor predicting tumor recurrence and long-term survival in HCC patients after liver resection.
5.pidemiological study and clinical analysis of 931 children with hand foot and mouth disease in Yantai
Ji-Guan YU ; You-De LIU ; Ling-Yan QIAO ; Chun-Juan WANG
Chinese Journal of Experimental and Clinical Virology 2011;25(5):374-376
Objective To discuss the epidemiological and clinical characteristics of the hospitalized children with hand foot and mouth disease (HFMD) in Yantai area.Methods Epidemiological and clinical data of HFMD children from 2009 to 2010 were summarized and analyzed retrospectively.Results Most of the infected ( 94.6% ) were under 5 years old and the ratio between male and female was 1.5∶1.Oral mucosal pox or ulcer as well as hand and foot rashes were observed in all 931 patients.Fever and neurological disorders occurred in 840( 90.2% )and 121 (13.0%) patients respectively.The incidence was positively correlated with air temperature ( r =0.887,P < 0.001 ),with a peak in April to September (88.9%).The ratio of children from countryside,total duration of fever,serum concentration of c-reacting protein (CRP) and fasting blood glucose(FBG) were significantly higher in severe cases than in those mild ones.Multivariate analysis showed longer mean duration of fever( Odds ratio[ OR],1.491 ;95% confidence interval[ CI] 1.170-1.901 ;P =0.001 ) and hyperglycemia( OR,1.124; 95% CI 1.016-1.245 ; P =0.024 )were independent risk factors of severity.Conclusion Children younger than 5 years old are susceptible to HFMD and most cases occur in April to September.The monthly incidence is positively correlated with temperature of that month.Longer duration of fever and hyperglycemia are independent risk factors for severity.Most cases could have a favorable prognosis after timely diagnosis and proper intervention.
6.Isobaric vapor-liquid equilibrium for methyldichlorosilane-dimethyldichlorosilane-benzene system.
Zu-Min QIU ; Xin-Liang XIE ; Shu-Xian YU ; Wen-You CHEN ; Feng-Xia XIE ; Juan LIU
Journal of Zhejiang University. Science. B 2005;6(10):1033-1037
The elucidation of vapor-liquid equilibrium (VLE) of the halogenated silane was necessary for the production of silicon derivatives, especially for methylvinyldichlorosilane, due to the lack of the relevant reports. Isobaric VLE for the system methyldichlorosilane-dimethyldichlorosilane-benzene and isobaric VLE of the three binary systems were measured with a new pump-ebulliometer at the pressure of 101.325 kPa. These binary compositions of the equilibrium vapor were calculated according to the Q function of molar excess Gibbs energy by the indirect method and the resulted VLE data agreed well with the thermodynamic consistency. Moreover, the experimental data were correlated with the Wilson, NRTL, Margules and van Laar equations by means of the least-squares fit, the acquired optimal interaction parameters were fitted to experimental vapor-liquid equilibrium data for binary systems. The binary parameters of Wilson equation were also used to calculate the bubble point temperature and the vapor phase composition for the ternary mixtures without any additional adjustment. The predicted vapor-liquid equilibrium for the ternary system was in a good agreement with the experimental results. The VLE of binary and multilateral systems provided essential theory for the production of the halogenated silane.
7.Inhibition of mutant-type p53 by a chimeric U6 maxizyme in hepatocellular carcinoma cell lines.
Xin-juan KONG ; Ju-sheng LIN ; Yu-hu SONG ; You-xin JIN
Chinese Journal of Hepatology 2005;13(10):759-762
OBJECTIVETo study the inhibition of maxizyme (Mz) directed against the mutant-type p53 gene (mtp53) at codon 249 in exon 7 (AGG --> AGT) both in cell-free system and in MHCC97 cell lines.
METHODSMaxizyme and control mutant maxizyme (G5 --> A5) were designed by computer and cloned into the eukaryotic expression vector pBSKneoU6 (pU6Mz, pU6asMz). Mz was driven by T7 RNA polymerase promoter in vitro. In the cell lines, U6 promoter was driven by RNA PolIII. The mutant type p53 gene fragment was cloned into the pGEM-T vector under the T7 promoter control. The 32P-labeled mtp53 transcript was the target RNA. Cold maxizyme transcripts were incubated with 32P-labeled target RNA in vitro. pU6Mz was introduced into MHCC97 cells by Lipofectamine2000 and mtp53 expression was analyzed by RT-PCR and Western blot.
RESULTSIn vitro cleavage showed that pU6Mz was very active with cleavage efficiency of 42% while pU6asMz was not. The wild type p53 was not cleaved. Partial down-regulation of mtp53 mRNA and mtp53 protein were observed in MHCC97 cells transfected with pU6Mz but not those with pU6asMz. The proliferation of MHCC cells was inhibited by MTT analysis.
CONCLUSIONOur findings suggest that the chimeric U6 maxizyme against the mtp53 is a new promising gene therapeutic agent in treating hepatocellular carcinoma.
Carcinoma, Hepatocellular ; genetics ; Cell Line, Tumor ; Genetic Therapy ; methods ; Genetic Vectors ; Humans ; Liver Neoplasms ; genetics ; Nucleic Acid Conformation ; Point Mutation ; Protein Conformation ; RNA, Catalytic ; RNA, Messenger ; chemical synthesis ; metabolism ; Recombinant Fusion Proteins ; Ribonuclease T1 ; pharmacology ; Tumor Suppressor Protein p53 ; genetics
8.ITF-2357 on inhibition myeloid leukemic cell lines cells proliferation in vitro and its mechanism.
Wen-juan YU ; Lei WANG ; Liang-shun YOU ; Chen MEI ; Qiu-ling MA ; Jie JIN
Chinese Journal of Hematology 2012;33(5):366-370
OBJECTIVETo explore the effect of ITF2357, a novel histone deacetylase (HDAC) inhibitor, on the growth, differentiation and apoptosis of acute myeloid leukemic (AML) cells and its mechanism.
METHODSAML cell lines kasumi-1 cells as a model for AML1-ETO positive, and THP1 cells for AML1-ETO negative, the leukemic cells proliferation was analyzed by MTT assay, expression of myeloid-specific differentiation antigen and cell cycle by flow cytometry, cell apoptosis by annexin V staining and flow cytometry. AML1-ETO, acetyl-histone, and caspase protein was analyzed by Western blot.
RESULTS0.5 µmol/L ITF2357 treatment significantly inhibited kasumi-1 cells proliferation, with the 48 h half inhibitory concentration (IC(50)) of 0.1 µmol/L. The initial inhibitory concentration of THP1 cell line was 5 µmol/L. ITF 2357 induced apoptosis of kasumi-1 cells in a time- and dose-dependent manner. A dose-dependent increase in early apoptosis occurred at 24 hours treatment and in late apoptosis at 48 hours treatment by ITF2357. Early apoptosis cells increased from (1.44 ± 1.52)% to (24.51 ± 5.79)%. Late apoptosis cells increased from (2.37 ± 2.8)% to (63.66 ± 1.56)%. ITF2357 induced AML1-ETO degradation by caspase-dependent pathway. 0.25 µmol/L ITF2357 induced a time- and dose-dependent increase in expression of myeloid cell surface protein CD13 and CD15. 5 µmol/L ITF2357 blocked the cells at G(0)/G(1) phase, G(0)/G(1) cells increased from (39.69 ± 6.56)% to (79.2 ± 6.51)% and s-phase cells declined from (60.12 ± 3.29)% to (18.97 ± 6.62)%. Kasumi-1 cells incubated with 0.5 µmol/L of ITF2357, AML1-ETO protein began to decrease at 24 hours and could hardly be detected at 96 hours. ITF2357 induced AML1/ETO degradation through a caspase-dependent mechanism. At the same time, acetylated H3 and H4 increased.
CONCLUSIONLow-dose HDAC inhibitor ITF2357 can effectively inhibit the AML cells proliferation, especially for AML1-ETO positive AML cells. It inhibits Kasumi-1 cells proliferation degradation of AML1-ETO protein expression, blocks the cells at G(0)/G(1) phase, and induces apoptosis and differentiation of the cells.
Acetylation ; Apoptosis ; drug effects ; Cell Differentiation ; drug effects ; Cell Line, Tumor ; Cell Proliferation ; drug effects ; Histone Deacetylase Inhibitors ; pharmacology ; Histones ; metabolism ; Humans ; Hydroxamic Acids ; pharmacology ; Oncogene Proteins, Fusion ; metabolism
9. Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in patients with acute-on-chronic liver failure (ACLF) after glucocorticoid therapy
Qi SONG ; Lin JIA ; Jinling DONG ; Juan LI ; Hongwei YU ; Qinghua MENG
Chinese Journal of Experimental and Clinical Virology 2017;31(6):554-557
Objective:
To evaluate the prognostic value of neutrophil-to-lymphocyte ratio (NLR) in patients with acute-on-chronic liver failure (ACLF) after glucocorticoid therapy.
Methods:
Thirty-six patients with acute-on-chronic liver failure (ACLF) were treated with glucocorticoid therapy, of whom 23 patients in the survival group and the other in the deceased group (